[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-360310-105":59,"doc-detail-360310-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","economic-burden-of-recurrence-in-early-stage-hepatocellular-carcinoma-treated-with-surgical-resection-or-local-ablation-in-the-united-states-a-retrospective-analysis-of-surveillance-epidemiology-and-end-resultsmedicare-data","Economic Burden of Recurrence in Early-Stage Hepatocellular Carcinoma Treated with Surgical Resection or Local Ablation in the United States - A Retrospective Analysis of Surveillance, Epidemiology and End Results–Medicare Data","","This retrospective analysis quantifies the economic burden associated with disease recurrence among patients with early-stage hepatocellular carcinoma (HCC) who received curative-intent therapy. Patients aged 66+ with complete radiological response after surgical resection or local ablation were identified from the SEER–Medicare database (2007–2017). Recurrence patients (n=309) and recurrence-free patients (n=302) were followed from index dates matched to time-to-recurrence distribution. Healthcare resource utilization and 2024 USD costs were compared after adjustment. Recurrence was associated with higher all-cause and HCC-related total monthly costs, driven largely by inpatient visits.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/economic-burden-of-recurrence-in-early-stage-hepatocellular-carcinoma-treated-with-surgical-resection-or-local-ablation-in-the-united-states-a-retrospective-analysis-of-surveillance-epidemiology-and-end-resultsmedicare-data/360310/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/economic-burden-of-recurrence-in-early-stage-hepatocellular-carcinoma-treated-with-surgical-resection-or-local-ablation-in-the-united-states-a-retrospective-analysis-of-surveillance-epidemiology-and-end-resultsmedicare-data/360310.png","ImageObject",300,407,{"name":92,"@type":93},"Stanley","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-26","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the study’s main goal?","Question",{"text":112,"@type":113},"To quantify the economic burden associated with recurrence in patients with early-stage HCC after curative-intent therapy in the United States.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were patients selected and followed?",{"text":117,"@type":113},"Patients aged 66+ with complete radiological response after surgical resection or local ablation were identified from SEER–Medicare (2007–2017), then assigned to recurrence or recurrence-free cohorts and followed from index dates.",{"name":119,"@type":110,"acceptedAnswer":120},"What cost differences were observed between recurrence and recurrence-free cohorts?",{"text":121,"@type":113},"Patients with recurrence had significantly higher mean all-cause and HCC-related total healthcare costs per patient per month, with inpatient visits identified as a major driver.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},360310,1790193989,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336477405376,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Adv Ther (2026) 43:2668–2685  \n[https://doi.org/10.1007/s12325-026-03562-y](https://doi.org/10.1007/s12325-026-03562-y)  \nORIGINAL RESEARCH  \nEconomic Burden of Recurrence in Early‑Stage Hepatocellular Carcinoma Treated with Surgical Resection or Local Ablation in the United States: A Retrospective Analysis of Surveillance, Epidemiology and End Results–Medicare Data  \nNeil Mehta · Liya Wang · Shital Kamble · Yan Song · Emily Gao · Abby Siegel · Angie Lax · Sanjana Sundaresan · Adina Zhang · Vicky Wei · Usha Malhotra  \nReceived: November 12, 2025 / Accepted: March 5, 2026 / Published online: April 8, 2026 © The Author(s) 2026  \nABSTRACT  \nIntroduction: Patients with early-stage hepatocellular carcinoma (HCC) who undergo curative-intent therapy remain at risk of disease recurrence. This study aimed to quantify the economic burden associated with disease recurrence in these patients.  \nMethods: Patients ≥ 66 years old with earlystage HCC who have achieved complete radiological response via surgical resection or local ablation were selected from the SEER–Medicare  \n\n| Prior Presentation: Part of the material in this manuscript was shared as a poster presentation (Poster 300) at the 2025 AMCP Nexus Annual Meeting held on October 27–30, 2025 in National Harbor, MD. |\n| --- |\n| Supplementary Information The online version contains supplementary material available at [https://doi.org/10.1007/s12325-026-03562-y](https://doi.org/10.1007/s12325-026-03562-y). |\n\nN. Mehta (*)  \nDivision of Gastroenterology, Department of Medicine, University of California, 400 Parnassus Avenue, \\#A740, San Francisco, CA 94117, USA [e-mail: Neil.Mehta@ucsf.edu](e-mail: Neil.Mehta@ucsf.edu)  \nL. Wang · S. Kamble · A. Siegel · U. Malhotra Merck & Co., Inc., Rahway, NJ, USA  \nY. Song · E. Gao · A. Lax · S. Sundaresan · A. Zhang Analysis Group, Inc., Boston, MA, USA  \nV. Wei  \nAnalysis Group, Inc., Menlo Park, CA, USA  \ndatabase (2007–2017) . Patients with evidence of recurrence following complete radiological response with curative-intent therapy were assigned to the recurrence cohort and followed from the date of recurrence (index date) . Patients without evidence of recurrence were included in the recurrence-free cohort and followed from an assigned index date based on the distribution of time between curative-intent therapy and recurrence in the recurrence cohort. Healthcare resource utilization (HRU) and costs (2024 USD) were compared between cohorts, adjusting for demographic and clinical characteristics. Results: A total of 309 patients with recurrence and 302 patients without recurrence were included. In the recurrence and recurrence-free cohorts, respectively, mean age was 75.0 and 74.5 years (p = 0.21), with male patients representing 66.3% and 60.3%(p = 0.12) . Mean follow-up was 20.8 and 22.0 months, respectively. Per patient per month (PPPM) mean allcause total healthcare costs were significantly higher in the recurrence cohort compared with the recurrence-free cohort ($14,697 vs $6223; adjusted cost difference [ACD] $9205; p\u003C 0.01) . Similarly, PPPM HCC-related total costs were $11,202 vs $3313 (ACD $10,021; p \u003C 0.01) . Inpatient visit costs were the major driver for the higher all-cause and HCC-related total costs in the recurrence cohort versus recurrence-free cohort.  \nConclusions: Findings suggest a significant HRU burden and high total healthcare costs for patients with early-stage HCC who experience disease recurrence after curative-intent therapy compared with patients who remain recurrence free. This underscores a need for future novel therapies that offer recurrence-free survival benefits and have the potential to reduce the economic burden of managing early-stage HCC.  \nPLAIN LANGUAGE SUMMARY  \nPeople with early-stage hepatocellular carcinoma (HCC), the most common type of liver cancer, can be treated with surgery or local ablation, with the intent of curing the disease. However, in some patients, the cancer may return after the completi","cbCaineunP161IYA","https://ap.wps.com/l/cbCaineunP161IYA","pdf",562675,18,"English","# Abstract\n## Introduction\n## Methods\n## Results\n## Conclusions\n# Plain Language Summary\n# Keywords\n# Key Summary Points\n## Why carry out this study?\n## What was learned from this study?","[{\"question\":\"What is the study’s main goal?\",\"answer\":\"To quantify the economic burden associated with recurrence in patients with early-stage HCC after curative-intent therapy in the United States.\"},{\"question\":\"How were patients selected and followed?\",\"answer\":\"Patients aged 66+ with complete radiological response after surgical resection or local ablation were identified from SEER–Medicare (2007–2017), then assigned to recurrence or recurrence-free cohorts and followed from index dates.\"},{\"question\":\"What cost differences were observed between recurrence and recurrence-free cohorts?\",\"answer\":\"Patients with recurrence had significantly higher mean all-cause and HCC-related total healthcare costs per patient per month, with inpatient visits identified as a major driver.\"}]","Economic Burden of Recurrence in Early-Stage Hepatocellular Carcinoma Treated with Surgical Resection or Local Ablation in the United States - A Retrospective Analysis of Surveillance, Epidemiology and End Results–Medicare Data | PDF",1790139570,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ffa9287976431267f13af5cf067bdb86.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/19685ed264c59a886e38a81ebb375f25.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6dbc8e93f870f322d8c393a0971ab0d3.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4d9490a639e7ab1ae2e22256af1dacfe.webp",980,1301]